Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）

NCT06546527 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: [177Lu]Lu-PSMA-137

Sponsor

Peking University First Hospital